$Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke. The effect of periprocedural medication: acetylsalicylic acid, unfractionated heparin, both, or neither (MR CLEAN-MED). Rationale and study design$

Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke. The effect of periprocedural medication: acetylsalicylic acid, unfractionated heparin, both, or neither (MR CLEAN-MED). Rationale and study design

BACKGROUND:<br>Despite evidence of a quite large beneficial effect of endovascular treatment (EVT) for ischemic stroke caused by anterior circulation large vessel occlusion, many patients do not recover even after complete recanalization. To some extent, this may be attributable to incomplete...

全面介紹

書目詳細資料
Main Authors:	Chalos, V, A van de Graaf, R, Roozenbeek, B, C G M van Es, A, M den Hertog, H, Staals, J, van Dijk, L, F M Jenniskens, S, J van Oostenbrugge, R, H van Zwam, W, B W E M Roos, Y, B L M Majoie, C, F Lingsma, H, van der Lugt, A, W J Dippel, D, MR CLEAN-MED investigators, Rothwell, P
格式:	Journal article
語言:	English
出版:	BioMed Central 2020

Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke. The effect of periprocedural medication: acetylsalicylic acid, unfractionated heparin, both, or neither (MR CLEAN-MED). Rationale and study design

相似書籍